Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Jabbour HN, Milne SA, Williams AR et al (2001) Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br J Cancer 85:1023–1031
2. Takiuchi T, Blake EA, Matsuo K et al (2018) Aspirin use and endometrial cancer risk and survival. Gynecol Oncol 148:222–232
3. Umar A, Steele VE, Menter DG, Hawk ET (2016) Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention. Semin Oncol 43:65–77
4. Gao J, Niwa K, Sun W et al (2004) Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci 95:901–907
5. Li HL, Zhang HW, Chen DD et al (2002) JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells. Acta Pharmacol Sin 23:631–637